Kushner Joshua

Co-founder Joshua Kushner buys 188,395 shares in 2 transactions at $16.97–$16.86, spending $3.2M as stock trades 31.4% below 52-week high.

Joshua Kushner, Co-Founder and Vice Chairman, purchased 188,395 shares across two separate transactions on 2024-11-20 and 2024-11-21 at a blended average price of $16.91, for a total outlay of $3,185,680.73. This purchase increased his holdings from 6,155,222 shares to 6,343,617 shares, a net addition of 3.1% to his pre-transaction position. The timing is notable: Oscar Health's stock is currently trading at $15.98, representing a -31.4% drawdown from its 52-week high of $23.28, and the company is unprofitable with net income of $-54,596,000.00 over its most recent full fiscal year, despite strong revenue growth of 47.9%. Over the preceding week (2024-11-11 through 2024-11-14), Kushner had already executed five separate buy transactions at this ticker, establishing a concentrated pattern of accumulation during a period of stock weakness. His cross-ticker open-market track record shows 5 prior buys, and none of his same-ticker purchases yet have measurable 90-day outcomes, leaving his historical execution accuracy at Oscar Health unestablished.

Co-Founder Kushner buys 344,522 shares ($5.4M) across 2 transactions at Oscar Health; stock down 31.4% from 52-week high.

Joshua Kushner, Co-Founder and Vice Chairman, executed 2 separate purchases totaling 344,522 shares for $5,444,343.41, raising his holdings to 6,155,222 shares. The transactions occurred at blended average price of $15.80, while the current price stands at $15.98—only marginally above execution. The stock is trading 31.4% below its 52-week high of $23.28, despite strong revenue growth of 47.9% year-over-year; however, the company remains unprofitable with a net income of -$54,596,000.00 in its most recent quarter. This represents a sustained accumulation pattern at the founder level following recent consecutive daily purchases (2024-11-11, 2024-11-12, 2024-11-13), though the limited measurable outcomes from same-ticker history and absence of prior cross-ticker 90-day positive returns at the time of this filing provide no confirmatory timing signal.

Kushner purchases 1,055,478 shares across 3 days at $13.67–$13.74 avg; holdings rise 22.2% to 5.81M shares.

Co-Founder and Vice Chairman Joshua Kushner executed 3 separate purchases totaling 1,055,478 shares for $14,429,982.49 over November 11–13, 2024 at prices between $13.58 and $13.74, raising his stake by 22.2% to 5,810,700 shares. The company is revenue-growing at +47.9% annually but currently unprofitable with net income of $-54,596,000 for the full year. The stock is trading at $13.48 today, down -42.1% from its 52-week high of $23.28 and down -23.3% over the past 30 days. This accumulation by a co-founder and senior executive during a period of material price decline provides direct visibility into insider capital deployment at current valuations, though the context of ongoing losses and recent downward price momentum warrants investor scrutiny of the company's path to profitability.